PHASEBIO PHARMACEUTICALS INC (PHAS)
US7172241090 - Common Stock
| MRQ (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 7.80M | 41.80M | 28.12M | 74.03M | 61.03M | |||
| Receivables | N/A | N/A | 0.00 | 1.23M | 230.00K | |||
| Other Current Assets | 3.76M | 6.98M | 12.03M | 3.57M | 1.36M | |||
| Total Current Assets | 11.56M | 48.78M | 40.15M | 78.82M | 62.63M | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.54M | 11.70M | 10.15M | 3.64M | 360.00K | |||
| Other Non-Current Assets | 58.00K | 57.00K | 60.00K | 30.00K | 40.00K | |||
| Total Non-Current Assets | 10.60M | 11.76M | 10.21M | 3.67M | 400.00K | |||
| TOTAL ASSETS | 22.17M | 60.54M | 50.36M | 82.49M | 63.03M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 4.07M | 5.41M | 5.36M | 2.38M | 0.00 | |||
| Accrued Expenses | 12.89M | 8.35M | 5.93M | 3.18M | 2.77M | |||
| Accounts Payable | 6.32M | 12.57M | 3.67M | 2.92M | 1.81M | |||
| Other Current Liabilities | 1.40M | 1.55M | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 24.68M | 27.88M | 14.96M | 8.48M | 4.58M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 1.36M | 6.77M | 12.33M | 7.50M | |||
| Other Non-Current Liabilities | 114.89M | 124.33M | 53.83M | 1.71M | 20.00K | |||
| Total Non-Current Liabilities | 114.89M | 125.69M | 60.60M | 14.04M | 7.52M | |||
| TOTAL LIABILITIES | 139.56M | 153.57M | 75.56M | 22.52M | 12.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -419.60M | -391.79M | -260.72M | -162.16M | -122.91M | |||
| Additional Paid In Capital | 302.18M | 298.74M | 235.52M | 222.13M | 173.84M | |||
| Common Shares | 50.00K | 48.00K | 30.00K | 30.00K | 30.00K | |||
| Treasury Stock | -24.00K | -24.00K | -20.00K | -20.00K | -20.00K | |||
| Shares Outstanding | 49.86M | 48.19M | 29.44M | 28.77M | 24.50M | |||
| Tangible Book Value per Share | -2.35 | -1.93 | -0.86 | 2.08 | 2.08 | |||
| Total Shareholders' Equity | -117.40M | -93.03M | -25.20M | 59.98M | 50.93M | |||
| TOTAL LIABILITIES AND EQUITY | 22.17M | 60.54M | 50.36M | 82.49M | 63.03M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | -0.01 | -0.27 | 0.21 | 0.15 | |||
| Current Ratio | 0.47 | 1.75 | 2.68 | 9.29 | 13.67 | |||
| Return On Assets (ROA) | -463.95% | -216.50% | -195.73% | -47.58% | -37.84% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -65.44% | -46.83% | |||
All data in USD